| Literature DB >> 30561613 |
Antonio Pelliccia1, Erik Ekker Solberg2, Michael Papadakis3, Paolo Emilio Adami1,4, Alessandro Biffi1, Stefano Caselli5, Andrè La Gerche6, Josef Niebauer7, Axel Pressler8,9, Christian M Schmied10, Luis Serratosa11,12, Martin Halle8,9, Frank Van Buuren13, Mats Borjesson14,15, Francois Carrè16, Nicole M Panhuyzen-Goedkoop17,18, Hein Heidbuchel19,20, Iacopo Olivotto21, Domenico Corrado22, Gianfranco Sinagra23, Sanjay Sharma3.
Abstract
Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, arrhythmogenic cardiomyopathy, and myo-pericarditis. Practicing cardiologists and sport physicians are required to identify high-risk individuals harbouring these cardiac diseases in a timely fashion in the setting of preparticipation screening or medical consultation and provide appropriate advice regarding the participation in competitive sport activities and/or regular exercise programmes. Many asymptomatic (or mildly symptomatic) patients with cardiomyopathies aspire to participate in leisure-time and amateur sport activities to take advantage of the multiple benefits of a physically active lifestyle. In 2005, The European Society of Cardiology (ESC) published recommendations for participation in competitive sport in athletes with cardiomyopathies and myo-pericarditis. One decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of cardiomyopathies and myo-pericarditis. The present document, therefore, aims to offer a comprehensive overview of the most updated recommendations for practicing cardiologists and sport physicians managing athletes with cardiomyopathies and myo-pericarditis and provides pragmatic advice for safe participation in competitive sport at professional and amateur level, as well as in a variety of recreational physical activities.Entities:
Year: 2019 PMID: 30561613 DOI: 10.1093/eurheartj/ehy730
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983